There's a lot of action on the OTT platform this March, thanks to some interesting film and Web series coming up.
Indoo Ki Jawaani is fun while it lasts, discovers Joginder Tuteja.
Protesting farmer leaders in the vulnerable age group Monday said they are not afraid of coronavirus and won't take vaccine jabs, even as the second phase of vaccination drive got underway to inoculate senior citizens and those above 45 with underlying medical conditions.
Joginder Tuteja lists the biggest box office successes with stars in uniform.
Joginder Tuteja looks at the biggest Bollywood hits in August in the last decade.
Aamir Khan's Mangal Pandey: The Rising released on August 12, 2005.
Joginder Tuteja looks at promising comedies getting ready to tickle your funny bone.
Joginder Tuteja looks back at Bollywood's wedding movies to see how well they have done in the past.
The Tattoo Murders doesn't make for relaxed viewing but you can give it a dekko if you dig the genre, says Joginder Tuteja.
There's a lot of action on the OTT front as well as in theatres.
Joginder Tuteja goes back in time to see the biggest June releases of the last 10 years.
While we await Shilpa's second innings in the movies, Joginder Tuteja looks at how well the top '90s actresses have done when they returned to acting.
Joginder Tuteja looks at the 10 Best Action Thrillers.
Akshay Kumar leads the show in a manner only he can. There is the right swag coming into the picture, but more important it is his deadpan style that works in favour of the character he is playing, applauds Joginder Tuteja.
Joginder Tuteja looks at Ajay Devgn's strong line-up, coming soon.
It's always exciting to see Bollywood's superstars pair up with actors they have never worked before.
OTT has been flooded with a number of film and Web series releases, and many of them are very entertaining.
With Hansal Mehta's Scam 1992 bringing it up so interestingly, Joginder Tuteja looks back at films that have dealt in the stock market.
Akshay-Katrina have been among the most successful on-screen couples till date and the same is expected to continue with Rohit Shetty's Sooryavanshi.
Joginder Tuteja looks at the biggest July hits in the last decade.
Joginder Tuteja lists how much money Salman's Eid releases have made over the years.
Joginder Tuteja looks at the new shows on our plate.
A start has been made to the Chakravyuh franchise and it is quite satisfying, notes Joginder Tuteja.
Joginder Tuteja looks at Akki's various cop roles through the years, and realises that he's played one as many as 17 times!
She's had as many as 15 theatrical releases, eight of which have been major hits.
Today, turning bad seems to have trendy, as A-listers are taking the villain route.
Joginder Tuteja looks at winning actor-director jodis, who have made Rs 100 crore movies and are returning for an encore.
Joginder Tuteja looks at films that didn't do well in theatres but became popular on satellite television or on OTT.
The curse of the second half prevents The Power from being the entertainer it could have been, notes Joginder Tuteja.
Things get better as the series proceeds, notes Joginder Tuteja.
LSD: Love Scandal and Doctors keeps you engrossed right through, applauds Joginder Tuteja.
The climax is what saves Koi Jaane Na from being a complete letdown, sighs Joginder Tuteja.
A large number of farmers on Tuesday squatted at the gates of the district headquarters in Karnal, locked in a showdown with Haryana's Bharatiya Janata Party-led government over a police lathi-charge last month.
Joginder Tuteja raises a toast to Aditya Chopra on his birthday, and looks at his 10 most successful productions.
Joginder Tuteja lists the films and Web shows coming up.
After impressing with his cop act in Mumbai Saga, Emraan Hashmi returns to his favourite genre -- the suspense thriller -- with Chehre.
Joginder Tuteja looks at filmmakers who have been away from the marquee for a long time, and are returning with a brand new film.
Joginder Tuteja looks at the film-maker's work over the years.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances